Sodium Di‐N‐Propylacetate (DPA) in the Treatment of Epilepsy:A Review

D. Simon,J. Penry
DOI: https://doi.org/10.1111/j.1528-1157.1975.tb04738.x
IF: 6.74
1975-11-01
Epilepsia
Abstract:The literature on clinical and expérimentalstudies of sodium dipropylacetate (DPA), a branched chain carboxylic acid with a unique antiepileptic structure, is critically reviewed. The clinical antiepileptic properties are evaluated by seizure type.
What problem does this paper attempt to address?